HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT
Formulations of the HIV compounds atazanavir and cobicistat such as tablet comprising atazanavir and cobicistat comprising having less than about 3% total cobicistat impurities after 8 weeks at 40 ° C and 75% relative humidity.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Croatian English |
Published |
25.11.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Formulations of the HIV compounds atazanavir and cobicistat such as tablet comprising atazanavir and cobicistat comprising having less than about 3% total cobicistat impurities after 8 weeks at 40 ° C and 75% relative humidity. |
---|---|
AbstractList | Formulations of the HIV compounds atazanavir and cobicistat such as tablet comprising atazanavir and cobicistat comprising having less than about 3% total cobicistat impurities after 8 weeks at 40 ° C and 75% relative humidity. |
Author | Koo, Otilia May Yue Nikfar, Faranak Varia, Sailesh A Kottala, Niranjan Kumar Tao, Jing |
Author_xml | – fullname: Koo, Otilia May Yue – fullname: Kottala, Niranjan Kumar – fullname: Nikfar, Faranak – fullname: Tao, Jing – fullname: Varia, Sailesh A |
BookMark | eNrjYmDJy89L5WQw8_AMUwgJcnUM8XX1C1Fw8w_yDfVxDPH091Pwd1NwDHGMcvRzDPMMUnD0c1Fw9nfydPYMDnEM4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8R5BAUYGRkaGhkZmISGGxsSpAgDX5ysq |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | FORMULACIJA ATAZANAVIRA I KOBICISTATA ZA LIJEČENJE HIV-A |
ExternalDocumentID | HRP20221126TT1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_HRP20221126TT13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:18:27 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Croatian English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_HRP20221126TT13 |
Notes | Application Number: HR2022P001126T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221125&DB=EPODOC&CC=HR&NR=P20221126T1 |
ParticipantIDs | epo_espacenet_HRP20221126TT1 |
PublicationCentury | 2000 |
PublicationDate | 20221125 |
PublicationDateYYYYMMDD | 2022-11-25 |
PublicationDate_xml | – month: 11 year: 2022 text: 20221125 day: 25 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | Bristol-Myers Squibb Holdings Ireland Unlimited Company |
RelatedCompanies_xml | – name: Bristol-Myers Squibb Holdings Ireland Unlimited Company |
Score | 3.4367404 |
Snippet | Formulations of the HIV compounds atazanavir and cobicistat such as tablet comprising atazanavir and cobicistat comprising having less than about 3% total... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221125&DB=EPODOC&locale=&CC=HR&NR=P20221126T1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt-I-ks49FMnSllbsBzUbw5exdi2KsI2t4r_vpXbOp70lOTgugct9JL87gHu0ADl6CqnenaZMpzRj-mM3Uf1N8lmSsnb-i-P2A8Md0ucxG9fgc4OFKeuEfpfFEVGjUtT3oryvl9skllX-rVw_JB-4tHhypGlpVXTcwXCmwzRrYNpRaIVCE8J0Yy2IzagiGhJDpT30o3tKHezRQMFSlv9tinMM-xGymxcnUHtfNeBQbFqvNeDAr168cVgp3_oUDNcbERnbXKoC_ATDN3_4UqaYSOgQLvkbD_jIiwkPLCLCgSe8V8nlGdw5thSujgJM_rY7ceOtsLLdPYf6fDHPLoD0GDNUPa20nfUpo0aSpHmftSid9fOeMW1dQnMXp6vd5Gs4UjOFs-uwJtSL1Vd2gwa3SG7Lg_oB4_B-iA |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7GFOebTsUfUwNK34rbmnT2oUiWtrS6tqNmY_gy1q5FEbqxVfz3TWrnfNpbyMFxCVzuvkvuC8C9iACZyBQSVZslRMU4JeqjFsv_TbJ5nJBO9tvH7Qe6O8LPEzKpweemF6bkCf0uyRGFRyXC34vyvF5ui1hW-bZy_RB_iKnFk8NNS6nQcVfAmS5RrL5pD0MrZApjphspQWQOK6HOBVTaEzl2T7qDPe7LtpTl_5jiHMH-UKjLi2Oova-a0GCbr9eacOBXN95iWDnf-gR01xsjHtmUSwJ-JOCbPxqUJSYUOohy-kYDOvYiRAMLsbDvMe-VU34Kd47NmasKA6Z_y5260dZY3tHOoJ4v8vQcUI8QXfJpJZ3UwATrcZxkBmljPDeynj5rX0Brl6bL3eJbaLjcH0wHXvByBYdSInvuuqQF9WL1lV6L4FvEN-Wm_QD-tYF7 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HIV+TREATMENT+FORMULATION+OF+ATAZANAVIR+AND+COBICISTAT&rft.inventor=Koo%2C+Otilia+May+Yue&rft.inventor=Kottala%2C+Niranjan+Kumar&rft.inventor=Nikfar%2C+Faranak&rft.inventor=Tao%2C+Jing&rft.inventor=Varia%2C+Sailesh+A&rft.date=2022-11-25&rft.externalDBID=T1&rft.externalDocID=HRP20221126TT1 |